We are live on ! Find out more
Stanley-Laman Group

Stanley-Laman Group Portfolio holdings

AUM $915M Turnover 11.67%
1-Year Est. Return 50.26%
This Fund
S&P 500
This Quarter Est. Return
-2.79%
1 Year Est. Return
+50.26%
3 Year Est. Return
+113.93%
5 Year Est. Return
+106.15%
10 Year Est. Return
+368.2%
AUM
$915M
AUM Growth
-$69.1M
Cap. Flow
-$11.3M
Cap. Flow %
-1.24%
Top 10 Hldgs %
19.78%
Holding
317
New
19
Increased
50
Reduced
138
Closed
18
Avg Time Held
2.3 years
Top 10 Avg Time Held
0.7 years
Top 20 Avg Time Held
1 year

Top Buys

Rank Stock Value
1
MDGL icon
Madrigal Pharmaceuticals
MDGL
+$6.86M
2
GBCI icon
Glacier Bancorp
GBCI
+$5.86M
3
MNTN icon
MNTN
MNTN
+$4.47M
4
MOS icon
Mosaic
MOS
+$4.43M
5
FITB icon
Fifth Third Bancorp
FITB
+$2.8M

Sector Composition

Rank Sector Weight
1 Technology 36.13%
2 Miscellaneous 15.81%
3 Industrials 11.61%
4 Energy 8.7%
5 Healthcare 6.83%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow Held Since
EGRX icon
201
DELISTED
Eagle Pharmaceuticals
EGRX
$11.4K ﹤0.01%
12,000
– –
2014 Q3
48 quarters
AON icon
202
Aon
AON
$70.5B
– –
-10,049
Closed -$3.33M –
GXO icon
203
GXO Logistics
GXO
$6.26B
– –
-79,094
Closed -$4.01M –
HBAN icon
204
Huntington Bancshares
HBAN
$30.3B
– –
-172,143
Closed -$3.05M –
HIG icon
205
Hartford Insurance Group
HIG
$36.4B
– –
-34,075
Closed -$4.52M –
INDA icon
206
iShares MSCI India ETF
INDA
$6.85B
– –
-28,000
Closed -$1.38M –
IONS icon
207
Ionis Pharmaceuticals
IONS
$4.62B
– –
-60,842
Closed -$4.82M –
LNTH icon
208
Lantheus
LNTH
$6.66B
– –
-67,964
Closed -$7.54M –
STRL icon
209
Sterling Infrastructure
STRL
$8.43B
– –
-395
Closed -$332K –
SYK icon
210
Stryker
SYK
$121B
– –
-757
Closed -$238K –
ZETA icon
211
Zeta Global
ZETA
$8.81B
– –
-232,253
Closed -$4.57M –

Similar funds

Stanley-Laman Group's Q3 2026 Portfolio in Review

As of Q3 2026, Stanley-Laman Group held 317 positions worth $915M, down 7% from $984M the previous quarter. Its ten largest holdings account for 20% of the portfolio.

Stanley-Laman Group's Q3 2026 filing shows 19 new, 50 increased, 138 reduced and 18 closed positions. Its largest new stake was Madrigal Pharmaceuticals: 12,984 shares worth $6.54M. The largest sale was Lantheus, an estimated $7.54M.

By sector, the portfolio is most concentrated in Technology at 36% of assets, down from 37% a quarter earlier, followed by Miscellaneous and Industrials.

  • Stanley-Laman Group's largest Q3 2026 buy was Madrigal Pharmaceuticals: 12,984 shares worth $6.54M.
  • Stanley-Laman Group added most to Marten Transport in Q3 2026, an estimated $1.82M increase.
  • Stanley-Laman Group's biggest Q3 2026 reduction was AAR, cutting an estimated $2.12M.
  • Stanley-Laman Group fully exited Lantheus in Q3 2026, selling an estimated $7.54M.
  • Stanley-Laman Group's ten largest holdings make up 20% of its $915M portfolio in Q3 2026.
  • Stanley-Laman Group opened 19 new positions and closed 18 in Q3 2026.
  • Stanley-Laman Group's portfolio value fell 7% quarter-over-quarter to $915M.

Based on Stanley-Laman Group's 13F filing for Q3 2026, filed 20 Oct 2026.